Alleviation of myelodysplastic syndrome-associated skin rush after treatment with decitabine.
Papaioannou
Maria
M
Department of Haematology, First Department of Internal Medicine, AHEPA University Hospital, School of Medicine, AUTH University Campus, AHEPA University Hospital, 54006 Thessaloniki, Greece.
Sapalidis
Konstantinos
K
Kotoula
Vassiliki
V
D000368:Aged; D000753:Anemia, Refractory / Q000150:complications* / Q000235:genetics / Q000473:pathology / Q000628:therapy; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001374:Azacitidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D001803:Blood Transfusion; D002872:Chromosome Deletion; D041322:Chromosomes, Human, Y / Q000235:genetics; D000077209:Decitabine; D005076:Exanthema / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine